The anti-PD-1 antibodies pembrolizumab and nivolumab have been approved for the treatment of several advanced malignancies, including malignant melanoma (MM) 1,2 and non-small-cell lung cancer (NSCLC)
British journal of pharmacology 166, 2741, doi: 10.1111/j.1476-5381.2011.01687.x (2012)
If eligible, receive a clinically developed and FDA-approved weight loss and prescription medication plan, insurance coordination, and ongoing support
Learn more: Not losing weight on Wegovy
It improves energy metabolism, provides additional support to muscles during physical activity, supports post-workout recovery, and may enhance aerobic capacity
As the prevalence of obesity rises, MedBridge remains at the forefront of medical weight management, helping patients achieve lasting results with the support of cutting-edge therapies like GLP-1 medications